The multinational Duchesnay with its affiliated companies is headquartered in Blainville, Quebec. 

The group consists of five pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad:

- Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health;
- Médunik Canada and Medunik USA, which provide treatments for rare diseases; and
- Analog Pharma, an American generic drugs company, specializing in authorized generics and orphan drugs.

From its state-of-the-art manufacturing plant in Blainville, Quebec, Duchesnay exports its innovative treatments to more than 50 countries.

Duchesnay and Medunik, through their proprietary research and development, and through partnerships, offer innovative treatments for a variety of medical conditions in women’s health, urology, oncology as well as for rare diseases.

The group of companies recognizes the dedication and professionalism of its employees and promotes a positive work culture and flexible work environment. It is deeply committed to environmental responsibility and giving back to the community through the support of various charitable organizations.

Pharmaceutical

Duchesnay

Éric Gervais

Carla Letourneau

Claude-André Boivin

Manon Vranderick

The Pharmaceutical and Regulatory Affairs team at Duchesnay is responsible for ensuring that all products comply with applicable regulations and standards in both domestic and international markets. They handle regulatory submissions, monitor drug safety, provide medical information, and ensure the continued efficacy and safety of treatments. Their work is pivotal in navigating the complex landscape of pharmaceutical regulations to bring innovative and safe treatments to patients worldwide.

Pharmaceutical and Regulatory Affairs

About

Team members